International Cardiovascular Research Journal
The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences
Outlines
The Cardiac Effects of Radiotherapy on Women with Breast Cancer Based on Laterality
Abstract
Background:
Recent advances in the early detection and management of breast cancer have conferred longer patient survival. Breast irradiation-induced cardiotoxicity has been associated with a decrease in the echocardiographic markers of myocardial function and an increase in cardiac mortality.
Objectives:
This study aimed to determine the cardiac effects of radiotherapy on patients with breast cancer based on cancer laterality.
Methods:
The present study assessed the records of 72 consecutive women with breast cancer who were referred to the Cardio-Oncology Department of Rajaie Cardiovascular Medical and Research Center between April 2017 and September 2020 and had baseline echocardiographic examinations and at least one follow-up echocardiographic examination within the first year of the initial examination. The patients were divided into left- and right-sided breast cancer groups to compare the results. The two groups were compared regarding the means of 2D Left Ventricular Ejection Fraction (LVEF), 3D LVEF, Global Longitudinal Strain (GLS), and Global Circumferential Strain (GCS) before and after radiotherapy. Analysis of Covariance (one-way ANCOVA) was used to compare the results (alpha = 0.05). All analyses were carried out using the SPSS software, version 26.
Results:
The changes in the means of 2D LVEF, 3D LVEF, GLS, and GCS were statistically significant among all the patients irrespective of cancer laterality (P < 0.001, P < 0.001, P = 0.001, and P = 0.002, respectively). However, no significant differences were observed between the left- and right-sided breast cancer groups vis-à-vis the means of 2D LVEF, 3D LVEF, GLS, and GCS (P = 0.44, P = 0.65, P = 0.21, and P = 0.25, respectively).
Conclusions:
The study results showed significant declines in the means of 2D LVEF, 3D LVEF, GLS, and GCS following radiotherapy. The patients with right-sided breast cancer exhibited a significant decrease in all the mentioned measures, whereas those with left-sided breast cancer showed no significant decline in post-radiotherapy speckle-tracking parameters. In addition, comparison of the patients with left- and right-sided breast cancers revealed no significant difference in the echocardiographic parameters of cardiotoxicity regarding cancer laterality.
References
- 1.The references are available in pdf.
Copyright
© 2021, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Dosimetric Comparison and TCP-NTCP Modeling for Lung, Heart, Left Anterior Descending, and Right Coronary Artery in Left-sided Breast Cancer Conventional and Hypofractionated Radiotherapy
Taheri H, Akhavan A, Tavakoli M, Moghareabed R, Kianinia M. Dosimetric Comparison and TCP-NTCP Modeling for Lung, Heart, Left Anterior Descending, and Right Coronary Artery in Left-sided Breast Cancer Conventional and Hypofractionated Radiotherapy. Int J Cancer Manag. 2021;14(12):e117987. doi: https://doi.org/10.5812/ijcm.117987
The Troponin-I Release in Patients with Left-Sided Early-Stage Breast Cancer Undergoing Adjuvant Whole Breast Radiotherapy: An Iranian Experience
Yousefi Kashi AS, Karimi M, Rakhsha A, Javadzadegan A, Taghizadeh-Hesary F. The Troponin-I Release in Patients with Left-Sided Early-Stage Breast Cancer Undergoing Adjuvant Whole Breast Radiotherapy: An Iranian Experience. Int J Cancer Manag. 2020;13(10):e107043. doi: https://doi.org/10.5812/ijcm.107043
Advanced Echocardiography Findings of HER2-Positive Breast Cancer Patients Following Anthracycline-Based Chemotherapy
Alizadehasl A, Haghazali M, Bazrafshan Drissi H, Askarinejad A, Emami SA, et al. Advanced Echocardiography Findings of HER2-Positive Breast Cancer Patients Following Anthracycline-Based Chemotherapy. Int Cardiovasc Res J. 2022;16(3):e128445. doi:
Echocardiographic Follow-Up in HER2 Positive and Negative Breast Cancer Patients: Is There a Sustained Decline in Left Ventricular Function Parameters Following Chemotherapy?
Haghazali M, Habibi Khorasani S, Alizadehasl A, Biglarian A, Mousavi SA, et al. Echocardiographic Follow-Up in HER2 Positive and Negative Breast Cancer Patients: Is There a Sustained Decline in Left Ventricular Function Parameters Following Chemotherapy?. Int Cardiovasc Res J. 2021;15(3):e117816. doi:
Assessment of Cardiac Function by Advanced Echocardiography in Breast Cancer Patients (HER2 Positive vs HER2 Negative)
Zohrian F, Alizadehasl A, Zahedi L, Ghaderian H, Anbiaee R, et al. Assessment of Cardiac Function by Advanced Echocardiography in Breast Cancer Patients (HER2 Positive vs HER2 Negative). Multidiscip Cardio Annal. 2020;11(2):e103004. doi: https://doi.org/10.5812/mca.103004
- Scopus by DOI: 0
Last Update: 0 months ago
- Scopus by Title: 4
Last Update: 0 months ago
- Scopus by Title (Ref): 4
Last Update: 0 months ago
- CrossRef: 0
Last Update: 5 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):
- Azin Alizadehasl:[PubMed][Scholar]
- Majid Maleki:[PubMed][Scholar]
- Feridoun Noohi:[PubMed][Scholar]
- Sara Adimi:[PubMed][Scholar]
- Seyed Amirhossein Emami:[PubMed][Scholar]
- Seyed Asadollah Mousavi:[PubMed][Scholar]
- Robab Anbiaie:[PubMed][Scholar]
- Payam Azadeh:[PubMed][Scholar]
- Hosein Kamranzadeh Fumani:[PubMed][Scholar]
- Soraya Salmanian:[PubMed][Scholar]
- Behshid Ghadrdoost:[PubMed][Scholar]
- Khadije Mohammadi:[PubMed][Scholar]
- Shirin Habibi Khorasani:[PubMed][Scholar]